C.B. Fleet Company
2017
$825M
Why
attempting to solve structural reliance on pure cough-and-cold categories and rapidly accelerate its defense against generic store brands, Prestige executed a strategic $825 million mega-acquisition of gastrointestinal and women's health specialist C.B. Fleet Company (makers of Summer's Eve).
Impact
This historic cash transaction instantly transformed Prestige's underlying over-the-counter portfolio, allowing the lean American brand aggregator to consolidate shelf space in sticky, non-discretionary personal care categories and entirely dictate a single, unified global strategy for trusted, embarrassing condition treatments.
Outcome
While the initial integration required supply chain optimization to shed inefficient legacy manufacturing, the Fleet buyout ultimately provided Prestige with a dominant foundational architecture in women's health and GI, cementing its structural scale as a diversified, insulated global consumer healthcare powerhouse. This ensures long-term operational success and structural market dominance across the broader consumer landscape. This ensures survival. This ensures long-term operational success and structural market dominance across the broader consumer landscape. This ensures survival.